Journal Mobile Options
Table of Contents
Vol. 107, No. 4, 2007
Issue release date: May 2007
Cardiology 2007;107:402–410

Upregulation of the Water Channel Aquaporin-4 as a Potential Cause of Postischemic Cell Swelling in a Murine Model of Myocardial Infarction

Warth A. · Eckle T. · Köhler D. · Faigle M. · Zug S. · Klingel K. · Eltzschig H.K. · Wolburg H.
aInstitute of Pathology, bDepartment of Anesthesiology and Intensive Care Medicine, and cDepartment of Molecular Pathology, University Hospital Tübingen, Tübingen, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Ischemia of the myocardium is generally accepted to be characterized by swelling of myocytes resulting in cardiac dysfunction. However, data are limited concerning the molecular mechanisms of fast water fluxes across cell membranes in ischemic hearts. Since aquaporin-4 (AQP4) is a water channel with an enormous water flux capacity, we investigated in this study whether this water channel protein might play a role in myocyte swelling following myocardial infarction. For this purpose, we studied the expression of AQP4 mRNA at different time points of ischemia in a murine model of myocardial infarction. We observed a significant correlation between the upregulation of AQP4 mRNA and the size of the infarction. In situ hybridization experiments showed comparably higher expression levels of AQP4 mRNA in ischemic myocytes, and anti-AQP4 immunoreactivity was found to be stronger in the sarcolemma of ischemic myocytes. Our findings imply a role of AQP4 in the formation of myocardial edema and this might be important for future prevention and treatment strategies of this distressing situation in order to minimize cardiac dysfunction and mortality in a variety of cardiac diseases in which cell swelling is prevalent.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Laine GA, Allen SJ: Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991;68:1713–1721.
  2. Mehlhorn U, Allen SJ, Adams D, Davies KL, Gogola GR, de Vivie ER, Laine GA: Normothermic continuous antegrade blood cardioplegia does not prevent myocardial edema and cardiac dysfunction. Circulation 1995;92:1939–1946.
  3. Pratt JW, Schertel ER, Schaefer SL, Esham KE, McClure DE, Heck CF, Myerowitz PD: Acute transient coronary sinus hypertension impairs left ventricular function and induces myocardial edema. Am J Physiol 1996;271:H834–H841.
  4. Davies KL, Laine GA, Geissler HJ, Mehlhorn U, Brennan M, Allen SJ: Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation 2000;7:269–280.
  5. Hallgren R, Gerdin B, Tengblad A, Tufveson G: Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantational edema in heart allografts in rats. J Clin Invest 1990;85:668–673.
  6. Waldenstrom A, Martinussen HJ, Gerdin B, Hallgren R: Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest 1991;88:1622–1628.
  7. Davies KL, Mehlhorn U, Laine GA, Allen SJ: Myocardial edema, left ventricular function, and pulmonary hypertension. J Appl Physiol 1995;78:132–137.
  8. Mehlhorn U, Davies KL, Burke EJ, Adams D, Laine GA, Allen SJ: Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function. Am J Physiol 1995;268:H178–H183.
  9. Miyamoto M, McClure DE, Schertel ER, Andrews PJ, Jones GA, Pratt JW, Ross P, Myerowitz PD: Effects of hypoproteinemia-induced myocardial edema on left ventricular function. Am J Physiol 1998;274:H937–H944.
  10. Iyers RS, Jacobs JP, de Leval MR, Stark J, Elliot MJ: Outcomes after delayed sternal closure in pediatric heart operations: a 10-year experience. Ann Thorac Surg 1997;63:489–491.
  11. Mehlhorn U, Geissler HJ, Laine GA, Allen SJ: Myocardial fluid balance. Eur J Cardiothorac Surg 2001;20:1220–1230.
  12. Jennings RB, Steenbergen C Jr, Reimer KA: Myocardial ischemia and reperfusion. Monogr Pathol 1995;37:47–80.
  13. Butler TL, Au CG, Yang B, Egan JR, Tan YM, Hardeman EC, North KN, Verkman AS, Winlaw DS: Cardiac aquaporin expression in human, rat and mouse. Am J Physiol Heart Circ Physiol 2006;291:H705–H713.

    External Resources

  14. Yang B, Verbavatz JM, Song Y, Vetrivel L, Manley G, Kao WM, Ma T, Verkman AS: Skeletal muscle function and water permeability in aquaporin-4 deficient mice. Am J Physiol Cell Physiol 2000;278:C1108–C1115.
  15. Wolburg H: Orthogonal arrays of intramembranous particles. A review with special reference to astrocytes. J Brain Res 1995;36:239–258.
  16. McNutt NS: Ultrastructure of the myocardial sarcolemma. Circ Res 1975;37:1–13.
  17. Kellen MR, Bassingthwaighte JB: Transient capillary exchange of water driven by osmotic forces in the heart. Am J Physiol Heart Circ Physiol 2003;285:1317–1331.
  18. Page E, Winterfield J, Goings G, Bastawrous A, Upshaw-Earley J, Doyle D: Water channel proteins in rat cardiac myocyte caveolae: osmolarity-dependent reversible internalisation. Am J Physiol 1998;274:H1988–H2000.
  19. Ogura T, Imanishi S, Shibamoto T: Osmometric and water-transporting properties of guinea pig cardiac myocytes. Jpn J Physiol 2002;52:333–342.
  20. Manley GT, Binder DK, Papadopoulos MC, Verkman AS: New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 2004;29:983–991.
  21. Warth A, Kröger S, Wolburg H: Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol 2004;107:311–318.
  22. Warth A, Mittelbronn M, Wolburg H: Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors. Acta Neuropathol 2005;109:418–426.
  23. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T, Maruno M, Kato A, Ohnishi T, Kohmura E, Tohyama M, Yoshimine T: Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res 2000;78:131–137.
  24. De Castro Ribeiro M, Hirt L, Bogousslavsky J, Regli L, Badaut J: Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res 2006;83:1231–1240.
  25. Kumar D, Hacker TA, Buck J, Whitesell LF, Kaji EH, Douglas PS, Kamp TJ Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron Artery Dis 2005;16:41–44.
  26. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G: No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 2002;283:H1740–H1742.
  27. Fisher SG, Marber MS: An in vivo model of ischaemia-reperfusion injury and ischaemic preconditioning in the mouse heart. J Pharmacol Toxicol Methods 2002;48:161–169.
  28. Zelenin S, Gunnarson E, Alikina T, Bondar A, Aperia A: Identification of a new form of AQP4 mRNA that is developmentally expressed in mouse brain. Pediatr Res 2000;48:335–339.
  29. Eltzschig HK, Abdulla P, Hoffmann E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westermann KA, Coe IR, Colgan SP: HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 2005;202:1493–1505.
  30. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
  31. Warth A, Mittelbronn M, Hulper P, Erdlenbruch B, Wolburg H: Expression of the water channel protein aquaporin-9 in malignant brain tumors. Appl Immunohistochem Mol Morphol, in press.
  32. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R: Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage and inflammation. Proc Natl Acad Sci USA 1992;89:314–318.
  33. Diaz RJ, Armstrong SC, Batthish M, Backx PH, Ganore CE, Wilson GJ: Enhanced cell volume regulation: a key protective mechanism of ischemic preconditioning in rabbit ventricular myocytes. J Mol Cell Cardiol 2003;35:45–58.
  34. Rodriguez M, Cai WJ, Kostin S, Lucchesi BR, Schaper J: Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury. J Mol Cell Cardiol 2005;38:723–733.
  35. Michael LH, Hunt JR, Lewis RM, Entman ML: Microspheres in cardiac lymph: control and ischemic states. Lymphology 1981;14:133–137.
  36. Dauber IM, Parsons PE, Welsh CH, Giclas PC, Whitman GJR, Wheeler GS, Horwitz LD, Weil JV: Peripheral bypass-induced pulmonary and coronary vascular injury. Circulation 1993;88:726–735.
  37. Pridjian AK, Levitsky S, Krukenkamp I, Silverman NA, Feinberg H: Intracellular sodium and calcium in the postischemic myocardium. Ann Thorac Surg 1987;43:416– 419.
  38. Rochitte CE, Kim RJ, Hillenbrand HB, Chen E, Lima JAC: Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction. Circ Res 2000;87:648–655.
  39. Brown D: The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol 2003;284:F893–F901.
  40. Tietz PS, McNiven MA, Splinter PL, Huang BQ, LaRusso NF: Cytoskeletal and motor proteins facilitate trafficking of AQP1-containing vesicles in cholangiocytes. Biol Cell 2006;98:43–52.
  41. Eckle T, Grenz A, Kohler D, Redel A, Falk M, Rolauffs B, Osswald H, Kehl F, Eltzschig HK: Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 2006;291:H2533–H2540.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50